Explore more publications!
Healthcare Times Denmark
Got News to Share?

Press Releases

Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment
11 hours ago

Focus on French HealthTech’s ecosystem : Panorama France HealthTech 2026 ‘s review: a mature, innovative and resilient sector facing a more demanding environment

Indeterminate GlobeNewswire, Inc.
Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq
Apr. 20, 2026

Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq

Indeterminate GlobeNewswire, Inc.
New Research Shows Shared Roots of Major Degenerative Diseases
Apr. 20, 2026

New Research Shows Shared Roots of Major Degenerative Diseases

Neutral EIN Presswire
Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028
4 hours ago

Ascendis Announces Redemption of All $575 Million of Outstanding 2.25% Convertible Senior Notes Due 2028

Indeterminate GlobeNewswire, Inc.
Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026
Apr. 19, 2026

Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026

Indeterminate GlobeNewswire, Inc.
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Apr. 19, 2026

Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

Indeterminate GlobeNewswire, Inc.
Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
12 hours ago

Enlivex Announces Second Regulatory Approval for Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire, Inc.
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine
Apr. 16, 2026

Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine

Indeterminate GlobeNewswire, Inc.
Health Experts Highlight 7 Reasons Seniors Should Stay Active
Apr. 13, 2026

Health Experts Highlight 7 Reasons Seniors Should Stay Active

Neutral EIN Presswire
BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026
Apr. 15, 2026

BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026

Indeterminate GlobeNewswire, Inc.
Weatherford Announces First Quarter 2026 Results
4 hours ago

Weatherford Announces First Quarter 2026 Results

Indeterminate GlobeNewswire, Inc.
Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe
Apr. 15, 2026

Arla Foods Ingredients Targets GLP-1 Companion Nutrition at Vitafoods Europe

Indeterminate GlobeNewswire, Inc.
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers
Apr. 14, 2026

Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers

Indeterminate GlobeNewswire, Inc.
Digital Health Monitoring Devices Market Size to Reach USD 35.12B by 2035 from USD 7.40B in 2026 (CAGR 18.90%)
Apr. 14, 2026

Digital Health Monitoring Devices Market Size to Reach USD 35.12B by 2035 from USD 7.40B in 2026 (CAGR 18.90%)

Indeterminate GlobeNewswire, Inc.
Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations
Apr. 14, 2026

Zealand Pharma Appoints Eric Rojas as Vice President and Head of Investor Relations

Indeterminate GlobeNewswire, Inc.
Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib’s Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer
13 hours ago

Allarity Therapeutics Presents Two AACR 2026 Posters Highlighting Stenoparib’s Potential in Colorectal Cancer as well as New Predictive Data Linking DRP® and Overall Survival in Ovarian Cancer

Indeterminate GlobeNewswire, Inc.
VELA Chairs Introduces 'Active Sitting' to Help Seniors Stay Active as Risks of Sedentary Behavior Rise
12 hours ago

VELA Chairs Introduces 'Active Sitting' to Help Seniors Stay Active as Risks of Sedentary Behavior Rise

Neutral EIN Presswire
Ascendis Pharma to List Ordinary Shares Directly on Nasdaq
Apr. 8, 2026

Ascendis Pharma to List Ordinary Shares Directly on Nasdaq

Indeterminate GlobeNewswire, Inc.
Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks
Apr. 1, 2026

Denmark Launches Lawsuit Against Meta Over Child Mental Health Risks

Indeterminate MENAFN
Owner: Sawsan Dababneh

MENAFN

Indeterminate
Owned By Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Jordan, Amman
Owner Country Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035
Mar. 31, 2026

Clinical Advancements in Gene Therapy for Neurological Diseases Market Outlook 2026–2035

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions